Spending on digital pathology equipment is rising as a result of the sheer rise in cancer cases. When it comes to blood cancer and lung cancer in particular, complications from late cancer diagnosis entail the utilisation of considerable capital resources during treatment and diagnosis.

NEWARK, Del: By 2022, the global Digital Pathology Market is anticipated to reach US$6,199 Mn, according to Future Market Insights. The market for digital pathology goods and services will increase at a CAGR of 13.5% during the projected period, reaching US$ 22,870.2 Mn by 2032.

Due to technological developments and the broad adoption of electronic medical records in the healthcare sector, digital pathology solutions are becoming more and more common. Cloud-based information systems are expected to expand at a CAGR of 16.9% through 2032, while on-premise systems will continue to dominate with US$ 626.8 Mn.

The rising use of advanced analytics in pharmaceutical and medical testing is one of the major drivers of the market for digital pathology. Analytics are being implemented by healthcare financing companies and governmental organisations through claim management and fraud prevention, which is driving the market’s expansion.

Surge in R&D in Digital Pathology to Augment Sales in Forthcoming Years

The digital pathology market has expanded significantly as a result of the industry’s increased spending in biosimilar research and development projects, particularly for the treatment of cancer and Covid-19.

Pharmaceutical companies are entrusting regulatory consultants, in-vitro diagnostics (IVD) facilities, clinical laboratories, and contract research organisations (CROs) with the task of developing biosimilars. These businesses are growing to provide their clients more affordable solutions, necessitating the usage of digital pathology devices to diagnose, investigate, and create efficient healthcare solutions.

Cancer diagnostic Opens New Avenues for Digital Pathology Companies

Spending on digital pathology equipment is rising as a result of the sheer rise in cancer cases. When it comes to blood cancer and lung cancer in particular, complications from late cancer diagnosis entail the utilisation of considerable capital resources during treatment and diagnosis. The demand for these systems in the cancer research sector is being driven by the success of digital pathology in research. Government investors are being encouraged to invest in digital pathology systems for clinical diagnostics as a result of this. Cancer diagnosis and therapy monitoring involve large financial outlays. This explains why there is a huge need for digital pathology solutions.

Competitive Landscape

• Danaher Corporation
• F. Hoffmann-La Roche AG
• Huron Technologies International Inc.
• Koninklijke Philips N.V.
• Olympus Corporation
• Hamamatsu Photonics K.K.
• Carl Zeiss AG
• Nikon Corporation
• 3DHISTECH Ltd.
• Hologic Inc.
• PerkinElmer, Inc.
• Visiopharm
• OptraSCAN, Inc.
• Inspirata, Inc.
• Sectra AB

Some of the recent developments in digital pathology market are as follows:

• In May 2021, Leica Biosystems joined the European Society for Digital and Integrative Pathology (ESDIP) to assist pathology labs in developing laboratories in accordance with modern digital pathology instruments.
• In March 2021, Roche inked a comprehensive merger agreement with GenMark Diagnostics to broaden its product and distribution channel for European consumers.

Key Segments Profiled in the Global Digital Pathology Market

Digital Pathology by Product Type:

• Digital Pathology Equipment
  • Whole Slide Scanners
    • Brightfield Slide Scanners
    • Fluorescence Slide Scanners
    • Combination Slide Scanners
  • Clinical Microscope
  • Tissue Microarrays
• Digital Pathology Software
  • Image Viewing and Analysis Software
    • On-premise
    • Cloud-based
• Digital Pathology Information Systems
  • On-premise
  • Cloud-based
• Digital Pathology Services
  • Installation and Integration Services
  • Consulting Services
  • Maintenance and Validation Services

Browse full Report@ https://www.futuremarketinsights.com/reports/Global-digital-pathology-market

Digital Pathology by Application:

• Clinical Pathology
• Molecular Diagnostics
• Basic & Applied Research
• Drug Development
• Others

Digital Pathology by End User:

• Hospitals
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Forensic Laboratories
• Research Institutes
• Contract Research Organizations (CROs)
• Clinics

Use promo code ->> FMITODAY to get a flat 20% discount

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Global Market Outlook

1.3. Demand Side Trends

1.4. Supply Side Trends

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain

Mortuary Bag Market Size: The global mortuary bag market is expected to grow at 4.8% CAGR to reach a market valuation of US$ 656.61 Million by the end of 2033, up from US$ 392.62 Million that was recorded for 2022.

Medical Rehabilitation Robotics Market Share: The global medical rehabilitation robotics market is forecasted to expand at 15.2% CAGR to reach a market valuation of US$ 1.76 Billion by the end of 2033, up from US$ 366.2 Million that was recorded for 2022.

Choroideremia Treatment Market Growth: The market is expected to attain a value pool of US$ 3.5 billion by the end of 2023, marking a substantial growth in demand. As we move forward, this trend is only set to continue, with global demand for Choroideremia Treatment projected to rise at a modest CAGR of 5.5% to reach an impressive US$ 6 billion by 2033.

Companion Animal Drugs Market Opportunity: The global companion animal drugs market is forecasted to expand at 4.4% CAGR to reach a market valuation of US$ 59.2 Billion by the end of 2033, up from US$ 36.7 Billion that was recorded for 2022.

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

LinkedIn| Twitter| Blogs | YouTube

For Sales Enquiries: [email protected]